Dividend compounder review

JAZZ

Jazz Pharmaceuticals PLC · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score47.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 15.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 14.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 13.5 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-356.1M
Free Cash Flow$1.1B
FCF Covers DividendUnknown
Debt / Equity1.20
P/E1,921.3
Revenue Growth 5Y12.5%
Net Margin0.7%
ROE0.7%
Price vs Trend22.1%
3Y Return84.7%
5Y Return27.3%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

JAZZ dividend review warning Warning · Warning

No usable dividend history found.